VOYA Investment Management’s CG Oncology CGON Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.88M Buy
57,291
+13,570
+31% +$769K ﹤0.01% 935
2025
Q4
$1.82M Sell
43,721
-4,265
-9% -$176K ﹤0.01% 1250
2025
Q3
$1.93M Buy
47,986
+32,877
+218% +$956K ﹤0.01% 1245
2025
Q2
$393K Buy
15,109
+1,079
+8% +$26K ﹤0.01% 1997
2025
Q1
$344K Sell
14,030
-133
-0.9% -$3.74K ﹤0.01% 2053
2024
Q4
$406K Sell
14,163
-840
-6% -$28.7K ﹤0.01% 2034
2024
Q3
$566K Buy
15,003
+7,182
+92% +$252K ﹤0.01% 1929
2024
Q2
$247K Buy
7,821
+865
+12% +$30K ﹤0.01% 2358
2024
Q1
$305K Buy
+6,956
New +$284K ﹤0.01% 2246

Other funds holding CGON

VOYA Investment Management's CGON Position: Q1 2026 in Review

VOYA Investment Management increased its CG Oncology (CGON) stake by 31% in Q1 2026, buying an estimated $769K and bringing the position to 57,291 shares worth $3.88M. The position accounts for ﹤0.01% of the portfolio, ranked #935.

VOYA Investment Management first reported a position in CGON in Q1 2024 and has held it in 9 quarters since. 233 funds tracked by Wall St. Rank hold CGON as of Q1 2026.

  • VOYA Investment Management held 57,291 shares of CG Oncology worth $3.88M as of Q1 2026.
  • VOYA Investment Management bought 13,570 CG Oncology shares in Q1 2026, an estimated $769K.
  • CG Oncology made up ﹤0.01% of VOYA Investment Management's portfolio in Q1 2026, its #935 holding.
  • VOYA Investment Management first reported a position in CG Oncology in Q1 2024 and has held it in 9 quarters since.
  • 233 funds tracked by Wall St. Rank held CG Oncology as of Q1 2026.

Based on VOYA Investment Management's 13F filing for Q1 2026, filed 12 May 2026.